I have been asked to describe the process used by the American Academy of Pediatrics (AAP) and American Heart Association (AHA) to evaluate the evidence for the purpose of developing recommendations for the Neonatal Resuscitation Program. This symposium is primarily interested in the recommendations regarding management of meconium during neonatal resuscitation, but I will first describe the neonatal program and the process used in development of all AHA and AAP resuscitation recommendations.
The Neonatal Resuscitation Program (NRP) is a standardized instruction in neonatal resuscitation. It includes a self-instructional textbook and a set of skills taught by instructors. The instructors first involved national faculty who were given the responsibility of training regional instructors in their respective states, who then trained hospital-based instructors, who in turn trained participants. The program was developed by collaboration of the AHA and AAP and is managed and revised by the NRP Steering Committee administered by the AAP. There have been over 2.2 million participants in the United States since inception of the NRP nearly 20 years ago, and the program has also been implemented in 106 other countries. Revisions are made approximately every 5 years.
The revision process involves six steps: define the issues, review the literature, debate the evidence, publish guidelines, produce educational materials, and deliver the program. 1 The first three steps are conducted in collaboration with the International Liaison Committee on Resuscitation (ILCOR), which then publishes a document entitled Consensus on Science and Treatment Recommendations (COSTR). Each of the resuscitation councils represented on ILCOR then develops separate resuscitation guidelines appropriate for their respective countries.
The neonatal resuscitation issues considered during the most recent review included topics such as the use of 100% oxygen versus room air, various issues related to temperature management, ventilation strategies during resuscitation, components and timing associated with volume expansion, glucose management following intensive resuscitation, use of CO 2 detectors for confirmation of tube placement, epinephrine dosing and routes of administration, ethical considerations regarding initiating and discontinuing resuscitation, as well as various aspects of managing meconium prior to, during and following delivery.
After the issues are defined, ILCOR representatives and consultants are asked to begin the evidence evaluation process by preparing worksheets on each topic. Worksheet development begins with an intensive review of the literature. Over 30 000 abstracted and critiqued references are cataloged in an Endnotes database maintained at the AHA. Pertinent studies are then classified according to their level of evidence, ranging from level 1 (randomized controlled trial), through levels 4 (historic, nonrandomized cohort study) and 6 (animal or mechanical model study), to level 8 (rational conjecture or common practice). Each study is also ranked as to the quality of evidence (fair, good or excellent) and whether the study is supportive, neutral or opposes the evidence. The neonatal resuscitation worksheets are available for review by accessing the NRP website (http://www.aap.org/nrp/ nrpmain), clicking on 'Science' and 'Evidence-Based Guidelines', and then accessing the link to the worksheets maintained on the AHA website. There are three worksheets addressing issues about meconium.
The worksheets serve as the focus for a series of ILCOR debates that take place over approximately 3 years, which culminates in the Evidence Evaluation (E-2) conference during which consensus is reached on the science. This conference forms the basis for the COSTR document, the most recent version of which was jointly published in Circulation 2 and Resuscitation 3 and the pediatric and neonatal portions republished in Pediatrics. 4 The NRP Steering Committee then considered the practical implications of COSTR in drafting the NRP Resuscitation Guidelines that were also published in Circulation 5 and Pediatrics.
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Three resuscitation-associated meconium issues were examined during the most recent evidence evaluation process. Does amnioinfusion reduce the incidence or severity of meconium aspiration syndrome? It has been hypothesized that infusion of saline into meconium-contaminated amniotic fluid will dilute the meconium and decrease the potential for developing obstruction of airways and development of meconium aspiration syndrome. Review of the literature revealed 23 reports supporting the hypothesis: amnioinfusion significantly reduced the frequency of meconium aspiration syndrome, of meconium below the cords and neonatal acidemia, and was associated with a lower overall cesarean section rate. Nine studies showed no significant benefit of amnioinfusion. Three reports suggested that any demonstrated benefit of amnioinfusion may have been a reflection of reversing fetal heart rate decelerations rather than due to dilution of meconium. There were also case reports of uterine rupture when amnioinfusion was administered during a trial of labor. In view of the conflicting data, insufficient input from the obstetrics profession, and knowledge of an ongoing randomized control trial, the Committee decided to take no position on amnioinfusion during this evidence evaluation cycle. Although the Guidelines were in press, the Fraser et al. 7 trial was published (as also reported at this conference), and the American College of Obstetrics and Gynecology released a Committee Opinion that 'routine prophylactic amnioinfusion for the dilution of meconium-stained amniotic fluid is not recommended.' 8 Should the current recommendation, to always perform intrapartum suctioning, be continued? Since the Carson et al.
9 study in 1976, there has been a generally accepted recommendation that babies born with meconium-stained amniotic fluid should have their nose, mouth and pharynx suctioned after delivery of the head, but before delivery of the shoulders (intrapartum suctioning). The recommendation was based on a probably erroneous assumption that most meconium aspiration syndrome (MAS) aspiration occurred during the establishment of air breathing and that removal of the meconium while the chest was still compressed in the birth canal could prevent MAS. The Carson et al. study reviewed retrospectively all births that occurred at the University of Colorado during three time periods (Table 1) .
In total, 12 to 16% of the babies born in 1970 to 1975 had meconium in their amniotic fluids. For the first 46 months (period 1), the standard had been not to perform intrapartum suctioning, but to perform direct endotracheal suctioning of all meconium-stained babies after delivery. This post-delivery practice had been initiated following the observation of Gregory et al. 10 in 1974 that 56% of meconium-stained neonates had meconium recovered from below the cords. For the next 10 months (period 2), Carson et al. performed intrapartum suctioning, continued to suction the trachea immediately following birth, and then performed a tracheobronchial lavage with normal saline. During the third epoch of 8 months (period 3), the intrapartum suctioning continued to be performed, but neonatal suction and lavage were less common. Even though there were no significant differences in the incidence of meconium aspiration syndrome among any of the epochs, the practice of intrapartum suctioning was recommended and adopted by the vast majority of clinicians for the next 30 years, probably because the practice appeared to be noninvasive and seemed logical.
However, the practice of intrapartum suctioning continued to be questioned by various obstetricians and neonatologists, and in 2000 to 2001 Vain et al.
11 conducted a randomized, multicenter, control trial of 2514 meconium-stained deliveries occurring in 10 centers in Argentina and 1 in the United States. Meconium-stained births were randomized to receive either pharyngeal suctioning of the fetus before delivery of the shoulders or no intrapartum suctioning. Although there were 5% protocol deviations, an intent-to-treat analysis revealed no significant difference in the incidence of meconium aspiration syndrome between the two groups. The relative risk was 0.9, with 95% confidence limits of 0.6 to 1.3. Primarily as a result of the Vain study, ILCOR and the latest edition of NRP have stated the following: 'Current recommendations no longer advise routine intrapartum oropharyngeal and nasopharyngeal suctioning for infants born to mothers with meconium staining of amniotic fluid (class I).' It should be noted that, although there was some disagreement during development of the recommendation, the NRP Steering Committee is on record as emphasizing that the new recommendation should not be interpreted to mean that intrapartum suctioning of meconium-stained babies is contraindicated, but merely that the previously recommended practice of routinely performing suctioning in such babies is no longer recommended. Several members felt that clearing of the oropharynx to facilitate the possible need for subsequent visualization of the trachea for direct suctioning, still seems reasonable. Is the current recommendation, to limit endotracheal suctioning only to the nonvigorous newborn, still valid? Traditional teaching has recommended that meconium-stained infants have endotracheal intubation immediately following birth and that suction be applied to the endotracheal tube as it is withdrawn. As noted above, this recommendation stemmed from the observation of Gregory et al. 10 who reported on experience with 1000 births, of whom 8.8% were meconium stained and 91% of those 88 had received direct endotracheal suction. Meconium was recovered from the trachea in 56% (46 babies) and 17% (8 patients) of those had had none in 'mouth or larynx' during laryngoscopy. Although this was not a control trial, from these observations, these clinician investigators recommended that, 'all infants born through thick or 'pea soup' meconium should have their trachea aspirated immediately after birthy'. Again, the recommendation was universally accepted and became the standard until Wiswell et al.
12 conducted a randomized multicenter control trial comparing the practice of performing endotracheal suctioning on all babies, versus only suctioning those babies who were nonvigorous. Vigorous was defined as strong respiratory effort, good muscle tone, and a heartrate greater than 100 beats per minute. Over 26 months, at 12 centers, 2094 meconium-stained neonates who were classified as 'vigorous' at birth, were randomized to receive endotracheal suctioning versus conservative therapy. There was no significant difference in the incidence of meconium aspiration syndrome or other lung disease between those suctioned versus those not suctioned. As a result, ILCOR and the NRP revised their recommendation in 2000 to limit endotracheal suctioning only to those babies who were meconium stained and not vigorous at birth. We finally stopped the practice of chasing the healthy baby around the delivery room with a laryngoscope.
There are still several unanswered questions regarding the appropriate management of the meconium-stained baby at birth that have not received definitive answers in the most recent COSTR document and the 2005 NRP Guidelines. First, is amnioinfusion an effective procedure for diluting meconium and reducing meconium aspiration syndrome? The above-mentioned Fraser et al. 7 trial and American College of Obstetrics and Gynecology statement 8 appear to have answered that question and will likely influence the next evidence evaluation documents. Second, is intrapartum suctioning contraindicated, rather than simply not recommended as a routine procedure? It seems unlikely that another larger control trial will be conducted to answer this question and there appears to be little evidence suggesting that intrapartum oropharyngeal suctioning is particularly hazardous. And finally, is direct endotracheal suctioning of the newborn of any description indicated following birth? As the original observation that formed the basis for the procedure was uncontrolled and was published over 30 years ago, and as there is increasing evidence that much of meconium aspiration occurs well before birth and as essentially every report of endotracheal suctioning since the report of Gregory et al. reports some morbidity associated with the procedure, it would seem well justified for there to be a modern-day large, randomized, multicenter trial comparing endotracheal suctioning versus no endotracheal suctioning of the nonvigorous meconium-stained newborn immediately following birth. Until such a study is performed, it is likely that subsequent NRP guidelines will continue to recommend that the procedure be performed. 
